Amino acid sequence surrounding the chondroitin sulfate attachment site of thrombomodulin regulates chondroitin polymerization

Biochemical and Biophysical Research Communications
Tomomi Izumikawa, Hiroshi Kitagawa

Abstract

Thrombomodulin (TM) is a cell-surface glycoprotein and a critical mediator of endothelial anticoagulant function. TM exists as both a chondroitin sulfate (CS) proteoglycan (PG) form and a non-PG form lacking a CS chain (α-TM); therefore, TM can be described as a part-time PG. Previously, we reported that α-TM bears an immature, truncated linkage tetrasaccharide structure (GlcAβ1-3Galβ1-3Galβ1-4Xyl). However, the biosynthetic mechanism to generate part-time PGs remains unclear. In this study, we used several mutants to demonstrate that the amino acid sequence surrounding the CS attachment site influences the efficiency of chondroitin polymerization. In particular, the presence of acidic residues surrounding the CS attachment site was indispensable for the elongation of CS. In addition, mutants defective in CS elongation did not exhibit anti-coagulant activity, as in the case with α-TM. Together, these data support a model for CS chain assembly in which specific core protein determinants are recognized by a key biosynthetic enzyme involved in chondroitin polymerization.

References

Sep 14, 1990·Biochemical and Biophysical Research Communications·K NawaY Marumoto
Nov 10, 1995·The Journal of Biological Chemistry·L ZhangJ D Esko
Aug 22, 2001·The Journal of Biological Chemistry·H KitagawaK Sugahara
Oct 1, 2004·Journal of Thrombosis and Haemostasis : JTH·S MollG C White
May 17, 2011·Critical Care : the Official Journal of the Critical Care Forum·Kazuma YamakawaTakeshi Shimazu
Jun 19, 2013·Biochimica Et Biophysica Acta·Tadahisa Mikami, Hiroshi Kitagawa

❮ Previous
Next ❯

Citations

Feb 19, 2020·Journal of Veterinary Emergency and Critical Care·Sarah GaudetteManuel Boller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.